What could expanding GLP-1 access on PBS look like?

Four-in-10 Australian adults may be eligible to use GLP-1 RA treatment for chronic weight management, a study has found Nearly eight million Australian adults were eligible for glucagon-like peptide-1 receptor agonist (GLP-1 RA) use for chronic weight management, according to an analysis of data from the Australian Bureau of Statistics 2022 National Health Survey. Research